US Patent 9340524 Androgen receptor modulator and uses thereof

Patent 9340524 was granted and assigned to Aragon Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Aragon Pharmaceuticals

Current Assignee

Aragon Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9340524

Date of Patent

May 17, 2016

Patent Application Number

14151106

Date Filed

January 9, 2014

Patent Citations Received

‌

US Patent 11654300 Joint optimization of radionuclide and external beam radiotherapy

‌

US Patent 12077554 CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

Patent Primary Examiner

‌

D. L. Jones

Patent abstract

Described herein is the androgen receptor modulator of formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9340524 Androgen receptor modulator and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API